Judie Barbara Alimonti (1960–2017) was a Canadian immunologist known for her research on the RVSV-ZEBOV Ebola vaccine.[1]

In 1991, Alimonti received a Bachelor of Science degree in microbiology from the University of British Columbia. She later earned a PhD in immunology from the University of Manitoba.[1]

Alimonti managed the Canadian testing of a human-grade Ebola vaccine at the National Microbiology Laboratory in Winnipeg, Manitoba.[2][3] When Ebola research at the lab began to founder, Alimonti set up a Skunkworks project within the lab to continue the research.[4] Alimonti was employed as a contract scientist at the lab and left their employment in 2015.[5][1]

Alimonti died of cancer in December 2017 in Ottawa.[1]

References

  1. 1 2 3 4 "Obit: Judie Alimonti was one of Canada's unsung scientific heroes | Ottawa Citizen". July 14, 2018. Archived from the original on January 25, 2020. Retrieved January 26, 2020.
  2. ↑ Branswell, Helen (January 7, 2020). "An Ebola vaccine was more than two decades in the making. Here are some key people who made it happen". Stats News. Archived from the original on 2020-01-07. Retrieved 2020-01-30.
  3. ↑ Malboeuf, Marie-Claude; Perreault, Mathieu (January 16, 2020). "Le vaccin contre l'Ebola aurait dû être disponible plus vite". La Presse (in French). Archived from the original on January 17, 2020. Retrieved January 30, 2020.
  4. ↑ Herder, Matthew; Gold, Richard (January 16, 2020). "The public science behind the 'Merck' Ebola vaccine". Stats News. Archived from the original on January 26, 2020. Retrieved January 26, 2020.
  5. ↑ Crowe, Kelly (January 1, 2020). "Canada's Ebola vaccine almost didn't happen, new study reveals". CBC News. Archived from the original on January 20, 2020. Retrieved January 30, 2020.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.